VBI Vaccines Inc Reviewing top-line data from PROTECT Transcript
Good morning, everyone. Thank you for standing by, and welcome to the VBI Vaccines Conference Call. (Operator Instructions) As a reminder, this conference call will be recorded. I'd now like to turn the conference over to Nell Beattie, Chief Business Officer at VBI Vaccines. Please go ahead.
Thank you, and thank you all for joining us on the call this morning as we announce the positive Phase III top line data from the PROTECT study of our trivalent hepatitis B vaccine, Sci-B-Vac. Joining me on the call this morning from VBI are Jeff Baxter, President and CEO; and Dr. Francisco Diaz-Mitoma, Chief Medical Officer. We do have slides to accompany this call, which you can access through the website portal or by going to the Investor page of our website under the Events/Presentation section.
Before we begin on Slide 2, I would like to remind you that this call will contain certain forward-looking statements. Specifically, I would like to remind everyone that all statements other than statements of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
